Foreword to Part Two

People with obesity and overweight are common in Australia and we often delay talking to our patients about their weight issues. Given this, the impact obesity has on individuals and their health, and now the issues with COVID-19, it is important that we remember how we can help.

In Part 2 of this obesity awareness collection, we reconsider the additional therapeutic approaches that we can employ to help people with obesity. These approaches include very low energy diets, pharmacotherapy and bariatric surgery.

The following articles on pharmacotherapy and surgical options for obesity have been collated from Medicine Today and its sister publication Endocrinology Today and all articles have been significantly updated by the authors.

Now, we need to help our patients in their struggle with their excess weight, we need to ask them about what help they need and we have to be aware of the range of options in our armamentarium – and be prepared to use them – especially at this time!

Professor Caterson is the Boden Professor of Human Nutrition and Director of the Boden Collaboration, The University of Sydney, Sydney, NSW.



Part 2. Pharmacological and surgical options

Article 1

Editorial  Obesity: once more – what can we do now?

What do healthcare professionals need to think about and how can they deliver additional therapeutic approaches to help people with obesity to lose weight now?
READ MORE

Article 2

Adjunctive therapies for obesity: VLEDs, pharmacotherapy and bariatric surgery

Very low energy diets (VLEDs), pharmacotherapy and bariatric surgery represent effective adjuncts to ongoing lifestyle modification for adults who have obesity, and may be used in combination or as single therapies.
READ MORE

Article 3

Liraglutide: for obesity, not just type 2 diabetes

Liraglutide is TGA approved as an adjunctive therapy for obesity, extending its indications for use beyond treatment of type 2 diabetes. What is its place in helping patients achieve and maintain weight loss?
READ MORE

Article 4

What’s new in weight loss management and surgery?

Dietary and lifestyle management underpin all treatment options, and pharmacotherapy has an adjuvant role in aiding appetite suppression. In people with morbid obesity and those with obesity and comorbidities, durable weight loss can be safely achieved with bariatric surgery, of which there are several surgical options.
READ MORE

Article 5

Bariatric surgery: positive and negative effects

Bariatric surgery is recognised as a legitimate treatment for obesity. It produces sustained weight loss, leading to remission of type 2 diabetes, reduction in mortality and improvement in many cardiac risk factors.
READ MORE

Not a registered user of our websites?

Sign up for access here »

This curated collection of articles is sponsored as an educational service by Novo Nordisk Australia.